mTOR inhibition in mice ameliorated spheroid pathology, demonstrating therapeutic potential of targeting this pathway in vivo.

Animal_Model Score: 0.500 Price: $0.50 Alzheimer's disease in_vivo Status: extracted

What This Experiment Tests

Animal_Model experiment designed to assess clinical efficacy targeting MTOR in in_vivo. Primary outcome: mTOR inhibition in mice ameliorated spheroid pathology, demonstrating therapeutic potential of targe

Description

In vivo mouse model with pharmacological mTOR inhibition

TARGET GENE

MTOR (Score: 0.419)

MODEL SYSTEM

in_vivo

ESTIMATED COST

TIMELINE

0 months

PATHWAY

PI3K/AKT/mTOR pathway

SOURCE

pmid_40065072

PRIMARY OUTCOME

mTOR inhibition in mice ameliorated spheroid pathology, demonstrating therapeutic potential of targeting this pathway in vivo.

Scoring Dimensions

Related Hypotheses (4)

APOE4-Specific Proteolytic Fragment Inhibition Therapy0.777

APOE-Dependent Autophagy Restoration0.877

Chronic mTORC1-ULK1 signaling blocks autophagy initiation in irradiated pericytes0.578

Metabolic Checkpoint Reprogramming via TREM2-mTOR Axis0.455

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.